1. Home
  2. NVCR vs AGM Comparison

NVCR vs AGM Comparison

Compare NVCR & AGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • AGM
  • Stock Information
  • Founded
  • NVCR 2000
  • AGM 1987
  • Country
  • NVCR Switzerland
  • AGM United States
  • Employees
  • NVCR N/A
  • AGM N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • AGM Finance Companies
  • Sector
  • NVCR Health Care
  • AGM Finance
  • Exchange
  • NVCR Nasdaq
  • AGM Nasdaq
  • Market Cap
  • NVCR 1.9B
  • AGM 2.2B
  • IPO Year
  • NVCR 2015
  • AGM N/A
  • Fundamental
  • Price
  • NVCR $19.11
  • AGM $186.41
  • Analyst Decision
  • NVCR Buy
  • AGM Hold
  • Analyst Count
  • NVCR 6
  • AGM 1
  • Target Price
  • NVCR $32.83
  • AGM $215.00
  • AVG Volume (30 Days)
  • NVCR 941.3K
  • AGM 43.2K
  • Earning Date
  • NVCR 07-24-2025
  • AGM 05-09-2025
  • Dividend Yield
  • NVCR N/A
  • AGM 3.22%
  • EPS Growth
  • NVCR N/A
  • AGM N/A
  • EPS
  • NVCR N/A
  • AGM 16.17
  • Revenue
  • NVCR $621,711,000.00
  • AGM $357,515,000.00
  • Revenue This Year
  • NVCR $5.56
  • AGM $9.70
  • Revenue Next Year
  • NVCR $9.15
  • AGM $8.26
  • P/E Ratio
  • NVCR N/A
  • AGM $11.53
  • Revenue Growth
  • NVCR 18.27
  • AGM N/A
  • 52 Week Low
  • NVCR $14.17
  • AGM $159.64
  • 52 Week High
  • NVCR $34.13
  • AGM $217.60
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 58.46
  • AGM 51.96
  • Support Level
  • NVCR $18.66
  • AGM $179.29
  • Resistance Level
  • NVCR $20.06
  • AGM $187.99
  • Average True Range (ATR)
  • NVCR 0.86
  • AGM 3.91
  • MACD
  • NVCR 0.19
  • AGM -0.32
  • Stochastic Oscillator
  • NVCR 71.98
  • AGM 39.73

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About AGM Federal Agricultural Mortgage Corporation

Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.

Share on Social Networks: